Kymera Therapeutics Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 3.1× Teradata Corporation Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Teradata Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| KYMR | TDC | |
|---|---|---|
Market Cap | $8.87B | $2.83B |
Volume | 779,107 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $127.31 | $37.88 |
52-Week Low | $55.80 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $2.52B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →